Study design of a phase 4, real-world study (COMPOSUR) to evaluate vibegron in patients with overactive bladder

Overactive bladder (OAB) is defined as urinary urgency accompanied by frequency and nocturia, with or without urge urinary incontinence (UUI). Vibegron, a selective β3-adrenergic receptor agonist approved in the ...

https://bmcurol.biomedcentral.com/articles/10.1186/s12894-023-01240-7

Source: BMC Urology - April 24, 2023 Category: Urology & Nephrology Authors: Roger R. Dmochowski, Eric S. Rovner, Michael J. Kennelly, Diane K. Newman, Laleh Abedinzadeh, Daniel Snyder, Elizabeth Thomas, Cornelia Haag-Molkenteller and Matt T. Rosenberg Tags: Study protocol Source Type: research

More News: Incontinence | Overactive Bladder | Overactive Bladder Syndrome | Study | Urology & Nephrology